# Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium

> **NCT05188131** · PHASE4 · COMPLETED · sponsor: **A.O.U. Città della Salute e della Scienza** · enrollment: 12 (actual)

## Conditions studied

- Hypopituitarism

## Interventions

- **DRUG:** Intravenous Infusion of Diclofenac Sodium
- **DRUG:** Intravenous Infusion of Placebo

## Key facts

- **NCT ID:** NCT05188131
- **Lead sponsor:** A.O.U. Città della Salute e della Scienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05188131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05188131, "Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05188131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*